Sep 2026
Nanoliposomal silymarin as a multi-mechanistic therapy for NAFLD: dose-dependent amelioration of hepatic steatosis, fibrosis, and oxidative stress in a rat model
Mohsen Akbaribazm, Z. Keshtmand, Zahraa Abdol-Al amerMohammad-Jawad et al.
· Comparative Clinical Patholo... · 0 citations